Epstein Secrets

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

Yoko lshikura Professor, Graduate School of Hitotsubashi University Japan International Corporate Strategy (ICS) Faisal Islam Economics Editor Channel 4 News United Kingdom Yoshinori Isozaki Managing Director Kirin Holdings Company Japan Limited Kiyohiko Ito Managing Director Keizai Doyukai (Japan

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

Yoko lshikura Professor, Graduate School of Hitotsubashi University Japan International Corporate Strategy (ICS) Faisal Islam Economics Editor Channel 4 News United Kingdom Yoshinori Isozaki Managing Director Kirin Holdings Company Japan Limited Kiyohiko Ito Managing Director Keizai Doyukai (Japan

iness School Google Inc. USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Ola

pA Japan Airlines Co. Ltd Babson College Japan External Trade Organization (JETRO) Global Environment Facility Medtronic Inc. Third Point LLC Channel 4 News Keizai Doyukai (Japan Association of Corporate Executives) Massachusetts Institute of Technology (MIT) Professor President and Chief Executive